Growing Demand for Glycated Albumin Tests in US Market Driven by Personalized Medicine
Monday, 11 March 2024, 16:30
Glycated Albumin Assay Market Growth
The US market for glycated albumin tests is expected to experience an annual growth rate of 8.7%. Personalized medicine in the US has significantly contributed to the increasing demand for tests aimed at managing diabetes, resulting in a positive market outlook.
Key Factors Driving Market Growth
- The rising number of diabetic patients aged 65 years and above.
- Government initiatives focused on improving disease diagnosis.
Challenges in Market Expansion
- Unfavorable reimbursement scenarios.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.